Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine versus mepivacaine for anesthesia in maxillary premolars with irreversible pulpitis
IRCT20180818040824N1Phase 3Completed
- Sponsor
- Yasouj University of Medical Sciences
- Start
- Feb 2018
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, double-blind trial of lidocaine, mepivacaine and epinephrine in irreversible pulpitis (2 arms), sponsored by Yasouj University of Medical Sciences. Primary endpoint: Patient pain during treatment. Started Feb 2018; status: completed.
02
Drugs
lidocainemepivacaineepinephrine
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on IRCT20180818040824N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180818040824N1.